Poynard T
Poynard T
APHP UPMC INSERM BioPredictive
Verifierad e-postadress på poynard.com
Titel
Citeras av
Citeras av
År
An algorithm for the grading of activity in chronic hepatitis C
P Bedossa, T Poynard
Hepatology 24 (2), 289-293, 1996
40621996
Natural history of liver fibrosis progression in patients with chronic hepatitis C
T Poynard, P Bedossa, P Opolon
The Lancet 349 (9055), 825-832, 1997
37411997
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis …
T Poynard, P Marcellin, SS Lee, C Niederau, GS Minuk, G Ideo, V Bain, ...
The Lancet 352 (9138), 1426-1432, 1998
29871998
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut, V Ratziu, L Pieroni, F Charlotte, Y Benhamou, T Poynard
The Lancet 357 (9262), 1069-1075, 2001
17532001
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu, F Charlotte, A Heurtier, S Gombert, P Giral, E Bruckert, ...
Gastroenterology 128 (7), 1898-1906, 2005
16362005
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Y Benhamou, M Bochet, V Di Martino, F Charlotte, F Azria, A Coutellier, ...
Hepatology 30 (4), 1054-1058, 1999
15051999
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ...
Gastroenterology 122 (5), 1303-1313, 2002
13172002
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
JG McHutchison, M Manns, K Patel, T Poynard, KL Lindsay, C Trepo, ...
Gastroenterology 123 (4), 1061-1069, 2002
12752002
Liver fibrosis in overweight patients
V Ratziu, P Giral, F Charlotte, E Bruckert, V Thibault, I Theodorou, L Khalil, ...
Gastroenterology 118 (6), 1117-1123, 2000
11952000
Viral hepatitis C
T Poynard, MF Yuen, V Ratzin, CL Lai
The Lancet 362 (9401), 2095-2100, 2003
11682003
Viral hepatitis B
CL Lai, V Ratziu, MF Yuen, T Poynard
The Lancet 362 (9401), 2089-2094, 2003
11332003
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
GL Davis, MJ Alter, H El–Serag, T Poynard, LW Jennings
Gastroenterology 138 (2), 513-521. e6, 2010
10392010
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta‐analysis
B Bernard, JD Grangé, EN Khac, X Amiot, P Opolon, T Poynard
Hepatology 29 (6), 1655-1661, 1999
9521999
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ...
Gastroenterology 139 (1), 120-129. e18, 2010
9052010
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht
Journal of hepatology 34 (5), 730-739, 2001
8952001
Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration
T Poynard, V Leroy, M Cohard, T Thevenot, P Mathurin, P Opolon, ...
Hepatology 24 (4), 778-789, 1996
8581996
Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography
M Friedrich-Rust, K Wunder, S Kriener, F Sotoudeh, S Richter, J Bojunga, ...
Radiology 252 (2), 595-604, 2009
7782009
Extrahepatic manifestations of chronic hepatitis C
P Cacoub, T Poynard, P Ghillani, F Charlotte, M Olivi, J Charles Piette, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1999
7621999
Estimating future hepatitis C morbidity, mortality, and costs in the United States.
JB Wong, GM McQuillan, JG McHutchison, T Poynard
American Journal of Public Health 90 (10), 1562, 2000
7322000
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C
T Poynard, V Ratziu, J McHutchison, M Manns, Z Goodman, S Zeuzem, ...
Hepatology 38 (1), 75-85, 2003
7282003
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20